FDAnews
www.fdanews.com/articles/71682-neose-strikes-deal-with-german-company

Neose Strikes Deal With German Company

April 29, 2005

Neose Technologies entered into a research, license and option agreement Thursday with BioGenerix AG of Germany that could earn Neose up to $61.5 million in research milestone payments. BioGenerix is planning to use Neose's proprietary glycopegylation technology to develop a long-acting, next-generation version of an undisclosed, currently marketed therapeutic protein. Neose of Horsham, Pa., and BioGenerix had previously announced a supply and option agreement for the protein.

Philadelphia Business Journal (http://www.bizjournals.com/philadelphia/stories/2005/04/25/daily46.html)